- Home
- GDTC vs NVNI Comparison
GDTC vs NVNI Comparison
Compare GDTC & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- NVNI
- Stock Information
- Founded
- GDTC 2018
- NVNI 2019
- Country
- GDTC Singapore
- NVNI Brazil
- Employees
- GDTC N/A
- NVNI N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- NVNI
- Sector
- GDTC Health Care
- NVNI
- Exchange
- GDTC Nasdaq
- NVNI Nasdaq
- Market Cap
- GDTC 21.5M
- NVNI 31.5M
- IPO Year
- GDTC 2023
- NVNI N/A
- Fundamental
- Price
- GDTC $1.89
- NVNI $0.49
- Analyst Decision
- GDTC Buy
- NVNI
- Analyst Count
- GDTC 1
- NVNI 0
- Target Price
- GDTC $5.00
- NVNI N/A
- AVG Volume (30 Days)
- GDTC 18.1K
- NVNI 12.4M
- Earning Date
- GDTC 01-01-0001
- NVNI 08-12-2025
- Dividend Yield
- GDTC N/A
- NVNI N/A
- EPS Growth
- GDTC N/A
- NVNI N/A
- EPS
- GDTC N/A
- NVNI N/A
- Revenue
- GDTC $368,838.00
- NVNI $31,250,627.00
- Revenue This Year
- GDTC $5.37
- NVNI $12.05
- Revenue Next Year
- GDTC N/A
- NVNI $15.02
- P/E Ratio
- GDTC N/A
- NVNI N/A
- Revenue Growth
- GDTC N/A
- NVNI 1491.58
- 52 Week Low
- GDTC $1.20
- NVNI $0.14
- 52 Week High
- GDTC $4.05
- NVNI $12.19
- Technical
- Relative Strength Index (RSI)
- GDTC 37.08
- NVNI 57.10
- Support Level
- GDTC $1.85
- NVNI $0.35
- Resistance Level
- GDTC $1.95
- NVNI $0.83
- Average True Range (ATR)
- GDTC 0.10
- NVNI 0.08
- MACD
- GDTC -0.02
- NVNI 0.03
- Stochastic Oscillator
- GDTC 28.00
- NVNI 34.62
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.